|
1.
|
Gold BG, Storm-Dickerson T and Austin DR:
The immunosuppressant FK506 increases functional recovery and nerve
regeneration following peripheral nerve injury. Restor Neurol
Neurosci. 6:287–296. 1994.PubMed/NCBI
|
|
2.
|
Gold BG, Katoh K and Storm-Dickerson T:
The immunosuppressant FK506 increases the rate of axonal
regeneration in rat sciatic nerve. J Neurosci. 15:7509–7516.
1995.PubMed/NCBI
|
|
3.
|
López-Vales R, García-Alías G, Forés J,
Udina E, Gold BG, Navarro X and Verdú E: FK 506 reduces tissue
damage and prevents functional deficit after spinal cord injury in
the rat. J Neurosci Res. 81:827–836. 2005.
|
|
4.
|
Saganová K, Orendácová J, Sulla I Jr,
Filipcík P, Cízková D and Vanický I: Effects of long-term FK506
administration on functional and histopathological outcome after
spinal cord injury in adult rat. Cell Mol Neurobiol. 29:1045–1051.
2009.PubMed/NCBI
|
|
5.
|
Lü DC, Yuan XH, Li HJ and Wei XL: An
experimental study of the neuroprotective effect of FK506 on acute
spinal cord injury in dogs. Zhonghua Wai Ke Za Zhi. 43:1088–1090.
2005.(In Chinese).
|
|
6.
|
Brown A, Ricci MJ and Weaver LC: NGF mRNA
is expressed in the dorsal root ganglia after spinal cord injury in
the rat. Exp Neurol. 205:283–286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kim DH, Gutin PH, Noble LJ, Nathan D, Yu
JS and Nockels RP: Treatment with genetically engineered
fibroblasts producing NGF or BDNF can accelerate recovery from
traumatic spinal cord injury in the adult rat. Neuroreport.
7:2221–2225. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lyons WE, George EB, Dawson TM, Steiner JP
and Snyder SH: Immunosuppressant FK506 promotes neurite outgrowth
in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci
USA. 91:3191–3195. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Takadera T, Sakamoto Y, Hizume Y and
Ohyashiki T: Cyclosporine A- and FK506-induced apoptosis in PC12
cells. Cell Biol Toxicol. 23:355–360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Price RD, Yamaji T and Matsuoka N: FK506
potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP
kinase pathway. Br J Pharmacol. 140:825–829. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jifeng H, Dezhong L, Qiongjiao Y, Huayong
Z and Shipu L: Evaluation of PRGD/FK506/NGF conduits for peripheral
nerve regeneration in rats. Neurol India. 58:384–391. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Allen AR: Surgery of experimental lesion
of spinal cord equivalent to crush injury of fracture dislocation
of spinal column: a preliminary report. JAMA. 57:878–880. 1911.
View Article : Google Scholar
|
|
13.
|
Basso DM, Beattie MS and Bresnahan JC: A
sensitive and reliable locomotor rating scale for open field
testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kimura N, Kumamoto T, Ueyama H, Horinouchi
H and Ohama E: Role of proteasomes in the formation of
neurofilamentous inclusions in spinal motor neurons of
aluminum-treated rabbits. Neuropathology. 27:522–530. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Millecamps S, Gowing G, Corti O, Mallet J
and Julien JP: Conditional NF-L transgene expression in mice for in
vivo analysis of turnover and transport rate of neurofilaments. J
Neurosci. 27:4947–4956. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Schumacher PA, Eubanks JH and Fehlings MG:
Increased calpain I-mediated proteolysis, and preferential loss of
dephosphorylated NF200, following traumatic spinal cord injury.
Neuroscience. 91:733–744. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Michael GJ, Kaya E, Averill S, Rattray M,
Clary DO and Priestley JV: TrkA immunoreactive neurones in the rat
spinal cord. J Comp Neurol. 385:441–455. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Josephson A, Widenfalk J, Trifunovski A,
Widmer HR, Olson L and Spenger C: GDNF and NGF family members and
receptors in human fetal and adult spinal cord and dorsal root
ganglia. J Comp Neurol. 440:204–217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Bowes M, Tuszynski MH, Conner J and Zivin
JA: Continuous intrathecal fluid infusions elevate nerve growth
factor levels and prevent functional deficits after spinal cord
ischemia. Brain Res. 883:178–183. 2000. View Article : Google Scholar
|
|
20.
|
Brunello N, Reynolds M, Wrathall JR and
Mocchetti I: Increased nerve growth factor receptor mRNA in
contused rat spinal cord. Neurosci Lett. 118:238–240. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Saganová K, Gálik J, Blaško J, Korimová A,
Račeková E and Vanický I: Immunosuppressant FK506: focusing on
neuroprotective effects following brain and spinal cord injury.
Life Sci. 91:77–82. 2012.PubMed/NCBI
|
|
22.
|
Toll EC, Seifalian AM and Birchall MA: The
role of immunophilin ligands in nerve regeneration. Regen Med.
6:635–652. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Keswani SC, Rosenberg B and Hoke A: The
use of GAP-43 mRNA quantification in high throughput screening of
putative neuroprotective agents in dorsal root ganglion cultures. J
Neurosci Methods. 136:193–195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Madsen JR, MacDonald P, Irwin N, et al:
Tacrolimus (FK506) increases neuronal expression of GAP-43 and
improves functional recovery after spinal cord injury in rats. Exp
Neurol. 154:673–683. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Asai A, Qiu J, Narita Y, et al: High level
calcineurin activity predisposes neuronal cells to apoptosis. J
Biol Chem. 274:34450–34458. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Nottingham S, Knapp P and Springer J:
FK506 treatment inhibits caspase-3 activation and promotes
oligodendroglial survival following traumatic spinal cord injury.
Exp Neurol. 177:242–251. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Gold BG, Densmore V, Shou W, Matzuk MM and
Gordon HS: Immunophilin FK506-binding protein 52 (not FK506-binding
protein 12) mediates the neurotrophic action of FK506. J Pharmacol
Exp Ther. 289:1202–1210. 1999.PubMed/NCBI
|
|
28.
|
Pratt WB and Toft DO: Steroid receptor
interactions with heat shock protein and immunophilin chaperones.
Endocr Rev. 18:306–360. 1997.
|
|
29.
|
Volonté C, Angelastro JM and Greene LA:
Association of protein kinases ERK1 and ERK2 with p75 nerve growth
factor receptors. J Biol Chem. 268:21410–21415. 1993.PubMed/NCBI
|
|
30.
|
York RD, Yao H, Dillon T, Ellig CL, Eckert
SP, McCleskey EW and Stork PJ: Rap1 mediates sustained MAP kinase
activation induced by nerve growth factor. Nature. 392:622–626.
1998. View Article : Google Scholar : PubMed/NCBI
|
